K. Asiedu, R. Scherpbier, and M. C. Raviglione, Buruli Ulcer Mycobacterium ulcerans infection. World Health Organization Global Buruli Ulcer Initiative, World Health Organization, 2000.

F. Portaels, M. T. Silva, and W. M. Meyers, Buruli ulcer, Clinics in Dermatology, vol.27, issue.3, pp.291-305, 2009.
DOI : 10.1016/j.clindermatol.2008.09.021
URL : https://hal.archives-ouvertes.fr/pasteur-00540470

K. M. George, L. Pascopella, D. M. Welty, and P. L. Small, A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells, Infection and Immunity, vol.68, issue.2, pp.877-883, 2000.
DOI : 10.1128/IAI.68.2.877-883.2000
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC97217/pdf

H. Hong, C. Demangel, S. J. Pidot, P. F. Leadlay, and T. Stinear, Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Natural Product Reports, vol.45, issue.3, pp.447-454, 2008.
DOI : 10.1039/b803101k
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730631

E. Marion, O. R. Song, T. Christophe, J. Babonneau, D. Fenistein et al., Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways, Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways, pp.1565-1576, 2014.
DOI : 10.1016/j.cell.2014.04.040
URL : https://hal.archives-ouvertes.fr/hal-01117565

E. Torrado, S. Adusumilli, A. G. Fraga, P. L. Small, A. G. Castro et al., Mycolactone-Mediated Inhibition of Tumor Necrosis Factor Production by Macrophages Infected with Mycobacterium ulcerans Has Implications for the Control of Infection, Infection and Immunity, vol.75, issue.8, pp.3979-3988, 2007.
DOI : 10.1128/IAI.00290-07

E. Torrado, A. G. Fraga, E. Logarinho, T. G. Martins, J. A. Carmona et al., IFN-??-Dependent Activation of Macrophages during Experimental Infections by Mycobacterium ulcerans Is Impaired by the Toxin Mycolactone, The Journal of Immunology, vol.184, issue.2, pp.947-955, 2010.
DOI : 10.4049/jimmunol.0902717

K. Asiedu and S. Etuaful, Socioeconomic implications of Buruli ulcer in Ghana: a three-year review, Am. J. Trop. Med. Hyg, vol.59, pp.1015-1022, 1998.

Q. B. Vincent, M. F. Ardant, A. Adeye, A. Goundote, J. P. Saint-andré et al., Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study, The Lancet Global Health, vol.2, issue.7, pp.422-430, 2014.
DOI : 10.1016/S2214-109X(14)70223-2

L. Marsollier, E. Deniaux, P. Brodin, A. Marot, C. M. Wondje et al., Protection against Mycobacterium ulcerans Lesion Development by Exposure to Aquatic Insect Saliva, PLoS Medicine, vol.280, issue.2, p.64, 2007.
DOI : 10.1371/journal.pmed.0040064.sd001
URL : https://hal.archives-ouvertes.fr/inserm-00700851

L. Marsollier, G. Prévot, N. Honoré, P. Legras, A. L. Manceau et al., Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin, International Journal of Antimicrobial Agents, vol.22, issue.6, pp.562-566, 2003.
DOI : 10.1016/S0924-8579(03)00240-1

M. Bolz, S. Kerber, G. Zimmer, and G. Pluschke, Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease, PLOS Neglected Tropical Diseases, vol.7, issue.8, p.4011, 2015.
DOI : 10.1371/journal.pntd.0004011.s001

A. Tanghe, J. Content, J. P. Van-vooren, F. Portaels, and K. Huygen, Protective Efficacy of a DNA Vaccine Encoding Antigen 85A from Mycobacterium bovis BCG against Buruli Ulcer, Infection and Immunity, vol.69, issue.9, pp.5403-5411, 2001.
DOI : 10.1128/IAI.69.9.5403-5411.2001

H. Dega, A. Bentoucha, J. Robert, V. Jarlier, and J. Grosset, Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice, Antimicrobial Agents and Chemotherapy, vol.46, issue.10, pp.3193-3196, 2002.
DOI : 10.1128/AAC.46.10.3193-3196.2002

T. S. Van-der-werf, W. T. Van-der-graaf, J. W. Tappero, and K. Asiedu, Mycobacterium ulcerans infection, The Lancet, vol.354, issue.9183, pp.1013-1018, 1999.
DOI : 10.1016/S0140-6736(99)01156-3

C. L. Gordon, J. A. Buntine, J. A. Hayman, C. J. Lavender, J. A. Fyfe et al., Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer, PLoS Neglected Tropical Diseases, vol.7, issue.10, p.1290, 2011.
DOI : 10.1371/journal.pntd.0001290.g002

K. H. Herbinger, M. Beissner, K. Huber, N. Y. Awua-boateng, J. Nitschke et al., Efficiency of Fine-Needle Aspiration Compared with Other Sampling Techniques for Laboratory Diagnosis of Buruli Ulcer Disease, Journal of Clinical Microbiology, vol.48, issue.10, pp.3732-3734, 2010.
DOI : 10.1128/JCM.01549-10

K. Muelder and A. Nourou, Buruli ulcer in Benin, The Lancet, vol.336, issue.8723, pp.1109-1111, 1990.
DOI : 10.1016/0140-6736(90)92581-2

D. S. Walsh, F. Portaels, and W. M. Meyers, Buruli ulcer (Mycobacterium ulcerans infection), Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.102, issue.10, pp.969-978, 2008.
DOI : 10.1016/j.trstmh.2008.06.006

W. M. Meyers, Mycobacterial Infections of the Skin, pp.291-377, 1995.
DOI : 10.1007/978-3-642-57863-2_9

L. Marsollier, R. Robert, J. Aubry, J. P. Saint-andré, H. Kouakou et al., Aquatic Insects as a Vector for Mycobacterium ulcerans, Applied and Environmental Microbiology, vol.68, issue.9, pp.4623-4628, 2002.
DOI : 10.1128/AEM.68.9.4623-4628.2002

E. Marion, S. Prado, C. Cano, J. Babonneau, S. Ghamrawi et al., Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage, PLoS ONE, vol.7, issue.4, p.33600, 2012.
DOI : 10.1371/journal.pone.0033600.s003

N. J. Tobias, T. Seemann, S. J. Pidot, J. L. Porter, L. Marsollier et al., Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer, PLoS Neglected Tropical Diseases, vol.54, issue.2, p.553, 2009.
DOI : 10.1371/journal.pntd.0000553.s006

L. Marsollier, P. Brodin, M. Jackson, J. Korduláková, P. Tafelmeyer et al., Impact of Mycobacterium ulcerans Biofilm on Transmissibility to Ecological Niches and Buruli Ulcer Pathogenesis, PLoS Pathogens, vol.63, issue.5, p.62, 2007.
DOI : 10.1371/journal.ppat.0030062.st001

F. S. Sarfo, P. J. Converse, D. V. Almeida, J. Zhang, C. Robinson et al., Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease, PLoS Neglected Tropical Diseases, vol.5, issue.3, p.2101, 2013.
DOI : 10.1371/journal.pntd.0002101.t001

D. R. Sherman, M. Voskuil, D. Schnappinger, R. Liao, M. I. Harrell et al., Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding ??-crystallin, Proc. Natl. Acad. Sci. USA, pp.7534-7539, 2001.
DOI : 10.1073/pnas.121172498

U. S. Gautam, S. Chauhan, and J. S. Tyagi, Determinants Outside the DevR C-Terminal Domain Are Essential for Cooperativity and Robust Activation of Dormancy Genes in Mycobacterium tuberculosis, PLoS ONE, vol.71, issue.1, p.16500, 2011.
DOI : 10.1371/journal.pone.0016500.t003

J. D. Mckinney, K. Höner-zu-bentrup, E. J. Muñoz-elías, A. Miczak, B. Chen et al., Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase, Nature, vol.406, issue.6797, pp.735-738, 2000.
DOI : 10.1038/35021074

C. Deshayes, S. K. Angala, E. Marion, I. Brandli, J. Babonneau et al., Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source, PLoS Neglected Tropical Diseases, vol.145, issue.(4), p.2502, 2013.
DOI : 10.1371/journal.pntd.0002502.s011

T. P. Stinear, A. Mve-obiang, P. L. Small, W. Frigui, M. J. Pryor et al., Giant plasmidencoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans, Proc. Natl. Acad. Sci. USA, pp.1345-1349, 2004.

T. P. Stinear, M. J. Pryor, J. L. Porter, and S. T. Cole, Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans, Microbiology, vol.151, issue.3, pp.683-692, 2005.
DOI : 10.1099/mic.0.27674-0

E. Marion, S. Eyangoh, E. Yeramian, J. Doannio, J. Landier et al., Seasonal and Regional Dynamics of M. ulcerans Transmission in Environmental Context: Deciphering the Role of Water Bugs as Hosts and Vectors, PLoS Neglected Tropical Diseases, vol.4, issue.22, p.731, 2010.
DOI : 10.1371/journal.pntd.0000731.s001
URL : https://hal.archives-ouvertes.fr/inserm-00691396

J. L. Porter, N. J. Tobias, H. Hong, K. L. Tuck, G. A. Jenkin et al., Transfer, stable maintenance and expression of the mycolactone polyketide megasynthase mls genes in a recombination-impaired Mycobacterium marinum, Microbiology, vol.155, issue.6, pp.1923-1933, 2009.
DOI : 10.1099/mic.0.027029-0

E. Coutanceau, P. Legras, L. Marsollier, G. Reysset, S. T. Cole et al., Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer, Microbes and Infection, vol.8, issue.8, pp.2075-2081, 2006.
DOI : 10.1016/j.micinf.2006.03.009

A. G. Fraga, A. Cruz, T. G. Martins, E. Torrado, M. Saraiva et al., Mycobacterium ulcerans Triggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression, Infection and Immunity, vol.79, issue.1, pp.421-430, 2011.
DOI : 10.1128/IAI.00820-10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019874

E. Coutanceau, L. Marsollier, R. Brosch, E. Perret, P. Goossens et al., Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cellular Microbiology, vol.34, issue.8, pp.1187-1196, 2005.
DOI : 10.1016/S0140-6736(99)01156-3

C. Demangel, T. P. Stinear, and S. T. Cole, Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009.
DOI : 10.1093/molbev/msm092

C. A. Huber, M. T. Ruf, G. Pluschke, and M. Käser, Independent Loss of Immunogenic Proteins in Mycobacterium ulcerans Suggests Immune Evasion, Clinical and Vaccine Immunology, vol.15, issue.4, pp.598-606, 2008.
DOI : 10.1128/CVI.00472-07

A. Tanghe, P. Y. Adnet, T. Gartner, and K. Huygen, A Booster Vaccination with Mycobacterium bovis BCG Does Not Increase the Protective Effect of the Vaccine against Experimental Mycobacterium ulcerans Infection in Mice, Infection and Immunity, vol.75, issue.5, pp.2642-2644, 2007.
DOI : 10.1128/IAI.01622-06

P. J. Converse, D. V. Almeida, E. L. Nuermberger, and J. H. Grosset, BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse, PLoS Neglected Tropical Diseases, vol.78, issue.3, p.985, 2011.
DOI : 10.1371/journal.pntd.0000985.s003

B. M. Saunders and A. M. Cooper, Restraining mycobacteria: Role of granulomas in mycobacterial infections, Immunology and Cell Biology, vol.67, issue.4, pp.334-341, 2000.
DOI : 10.1046/j.1365-2567.1999.00663.x

D. O. Co, L. H. Hogan, S. I. Kim, and M. Sandor, Mycobacterial granulomas: keys to a long-lasting host???pathogen relationship, Clinical Immunology, vol.113, issue.2, pp.130-136, 2004.
DOI : 10.1016/j.clim.2004.08.012

J. L. Casanova and L. Abel, : The Human Model, Annual Review of Immunology, vol.20, issue.1, pp.581-620, 2002.
DOI : 10.1146/annurev.immunol.20.081501.125851

D. Diaz, H. Döbeli, D. Yeboah-manu, E. Mensah-quainoo, A. Friedlein et al., Use of the Immunodominant 18-Kilodalton Small Heat Shock Protein as a Serological Marker for Exposure to Mycobacterium ulcerans, Clinical and Vaccine Immunology, vol.13, issue.12, pp.1314-1321, 2006.
DOI : 10.1128/CVI.00254-06

Y. Stienstra, W. T. Van-der-graaf, G. J. Te-meerman, T. H. The, L. F. De-leij et al., Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors, Tropical Medicine and International Health, vol.63, issue.7, pp.554-562, 2001.
DOI : 10.1016/S0140-6736(99)02301-6

N. Strbo, N. Yin, and O. Stojadinovic, Innate and Adaptive Immune Responses in Wound Epithelialization, Advances in Wound Care, vol.3, issue.7, pp.492-501, 2014.
DOI : 10.1089/wound.2012.0435

M. H. Kim, W. Liu, D. L. Borjesson, F. R. Curry, L. S. Miller et al., Dynamics of Neutrophil Infiltration during Cutaneous Wound Healing and Infection Using Fluorescence Imaging, Journal of Investigative Dermatology, vol.128, issue.7, pp.1812-1820, 2008.
DOI : 10.1038/sj.jid.5701223

S. Chauhan, D. Sharma, A. Singh, A. Surolia, and J. S. Tyagi, Comprehensive insights into Mycobacterium tuberculosis DevR (DosR) regulon activation switch, Nucleic Acids Research, vol.39, issue.17, pp.7400-7414, 2011.
DOI : 10.1093/nar/gkr375
URL : http://doi.org/10.1093/nar/gkr375

P. Tafelmeyer, C. Laurent, P. Lenormand, J. C. Rousselle, L. Marsollier et al., Comprehensive proteome analysis of Mycobacterium ulcerans and quantitative comparison of mycolactone biosynthesis, PROTEOMICS, vol.123, issue.15, pp.3124-3138, 2008.
DOI : 10.1002/pmic.200701018

P. Albuquerque and A. Casadevall, Quorum sensing in fungi ??? a review, Medical Mycology, vol.50, issue.4, pp.337-345, 2012.
DOI : 10.3109/13693786.2011.652201

I. Castillo-juárez, T. Maeda, E. A. Mandujano-tinoco, M. Tomás, B. Pérez-eretza et al., Role of quorum sensing in bacterial infections, World J. Clin. Cases, vol.3, pp.575-598, 2015.

Y. H. Dong, L. Y. Wang, and L. H. Zhang, Quorum-quenching microbial infections: mechanisms and implications, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.96, issue.9, pp.1201-1211, 2007.
DOI : 10.1073/pnas.96.9.4832
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435583

E. Goo, J. H. An, Y. Kang, and I. Hwang, Control of bacterial metabolism by quorum sensing, Trends in Microbiology, vol.23, issue.9, pp.567-576, 2015.
DOI : 10.1016/j.tim.2015.05.007

G. F. Kaufmann, J. Park, and K. D. Janda, Bacterial quorum sensing: a new target for anti-infective immunotherapy, Expert Opinion on Biological Therapy, vol.20, issue.6, pp.719-724, 2008.
DOI : 10.1038/nature06279

K. Wong, S. Bumpstead, L. Van-der-weyden, L. G. Reinholdt, L. G. Wilming et al., Sequencing and characterization of the FVB/NJ mouse genome, Genome Biology, vol.13, issue.8, p.72, 2012.
DOI : 10.1093/nar/29.1.308

N. S. Merle, R. Noe, L. Halbwachs-mecarelli, V. Fremeaux-bacchi, and L. T. Roumenina, Complement System Part II: Role in Immunity, Frontiers in Immunology, vol.1950, issue.190, p.257, 2015.
DOI : 10.4049/jimmunol.1203548
URL : https://hal.archives-ouvertes.fr/hal-01216398

M. A. Mashruwala, A. K. Smith, D. R. Lindsey, M. Moczygemba, R. A. Wetsel et al., A defect in the synthesis of Interferon-?? by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis, Tuberculosis, vol.91, pp.91-82, 2011.
DOI : 10.1016/j.tube.2011.10.016